52.3 F
Washington D.C.
Saturday, January 28, 2023

Tom French

Mr. Thomas French has a 30-year professional track record creating shareholder value in start-ups and turn-arounds. Most recently he was involved in the turn-around of Zoono, an innovative biotech company, by securing both EPA and FDA approval of disinfection tech, and building a 20-item line of consumer and commercial products. In addition, he achieved nation-wide distribution with a #1 Pharmacy retailer for the firm.
0 written articles